baber/WOPTO huggingface dataset:
Patent JP-2001507239-A (JP)
Title: Ｓｍａｄ２のリン酸化とｓｍａｄ４との相互作用
IPC: G01N33/566
Filed: 1998-05-20
Abstract: (57)【要約】
本発明は、Ｓｍａｄ２タンパクのリン酸化活性に重要なアミノ酸残基、およびＳｍａｄ２ポリペプチド断片および生物学的に機能のある、その変異型を記載する。さらにＳｍａｄ２の顕性不活性変異型およびそれに対する抗体を含む。またそのような変異型をコードする核酸を含む。経路限定Ｓｍａｄタンパクのリン酸化されたＣ末端端部に選択的に結合する抗体も提供する。そのような核酸とポリペプチドを利用するための方法と産物も提供する。
Patent JP-2001320074-A (JP)
Title: Electromotive force type infrared detector cell
Inventor: SCHIMERT THOMAS R
IPC: H01L31/0296
Filed: 1995-03-15
Abstract: PROBLEM TO BE SOLVED: To increase the detectability and diode resistance by reducing the volume and the cross-sectional area of a photovolatic diode without deteriorating the infrared ray absorption efficiency. SOLUTION: This infrared detector cell is provided with a plurality of linear segments disposed at equal intervals, and each linear segment forms an optical grating. Each segment is selectively added with impurities in the horizontal direction and forms a photovolatic diode. The linear segment is brought into ohmic contact between conductors to generate a single cell detection signal. The cell forms a diffractive resonance optical cavity. The array constituted by the cells generates an infrared image. There is disclosed a cell structure for receiving both a one-dimensional linearly polarized radiation and a two-dimensional unpolarized radiation.
Patent MX-158915-A (MX)
Inventor: KABL WERNER
IPC: G08B25/00
Filed: 1985-05-20
Abstract: 1. A signal display device, in particular for signal arrays using racks of digital signal or carrier frequency systems, comprising a series circuit of luminescence diodes (A', B'...N') for the display of signals and a current source connected to a signalling voltage (Us ), comprising relays (A, B...N) which can each be driven by a signal, comprising first relay contacts to each relay (A, B...N) which can effect a short-circuit of the respectively assigned luminescence diode (A', B'...N') or a connection thereof to the signalling voltage (Us ) and comprising second relay contacts (a2, b2...n2) to each relay (A, B...N) as indicator contacts to collective lines which lead to a light signalling device, an acoustic signalling device and/or a central operation observation unit, characterised in that the current source consists of a transistor (T) with an emitter-resistor (R2), the base of the transistor (T) is assigned, as reference voltage source, a Zener diode (Z) whose series resistor (R1) is connected to a supply input (S) and that the first relay contacts consist of change-over contacts (n1', b1'...n1') which, when the respective assigned luminescence diodes (A', B'...N') are released, establish a connection to the supply input (S) from that side of the luminescence diode (A', B'...N') remote from the transistor, directly in respect of the luminescence diode (N') furthest from the transistor (T), and via a decoupling diode (DA, DB) in respect of the other luminescence diodes (A', B').
Patent NZ-205794-A (NZ)
Title: Anti-photocopying paper with certain reflection spectral response
Inventor: N A GARDNER
IPC: G03C5/08
Filed: 1983-09-28
Abstract: A document has information appearing thereon, with at least a portion of the information being located on a front face of a portion of the document. The front face portion has a colour with a sufficiently low reflection spectral response to render the document portion substantially incapable of being photocopied in an information-readable manner. The document portion is capable of transmitting visible light from the rear face to the front face to cause sufficient contrast between the relatively non-translucent information and the transmitted light to enable the information to be read by a human eye viewing the front face of the document when visible light is transmitted through the document from the rear face to the front face.
Patent NZ-208846-A (NZ)
Title: Glass fibre reinforced resin applying machine for u-shaped cross-section mould
Inventor: MARTIN R J
IPC: B29C41/08
Filed: 1984-07-10
Abstract: A machine for manufacturing a unitary glass fibre reinforced body shell includes a carriage which is movable along the mold and a turntable which is mounted on a carriage for rotation about a first axis extending in the direction of longitudinal movement of the carriage. An arm is slidably mounted on the turntable for radial movement and a dispenser is located on the arm for dispensing glass fibre reinforced resin onto the surface of the mold. A guidance system is provided which interconnects the turret and the slidable arm and is operable to cause the arm to reciprocate with respect to the turret in a radial direction to maintain a substantially constant length of trajectory extending between the dispenser and the wall of the mold. A drive system is provided for rotatably driving the turret about the axis. The carriage is normally stored on a mobile end cap which may be moved from one mold to another and serves to close one end of the mold. A canopy is mounted with one end connected to the mold and the other end connected to the dispenser carriage such that as the dispenser carriage moves along the mold, the canopy is deployed to cover the open upper end of the mold to form an enclosed chamber from which fumes may be extracted.
Patent NZ-213840-A (NZ)
Title: Dichloroaniline derivatives and pharmaceuticals
Inventor: SKIDMORE I F
IPC: A61K31/395
Filed: 1985-10-16
Abstract: The invention provides compounds of the general formula (I)   <CHEM>  wherein X represents a C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene chain and Y represents a bond, or a C1-4 alkylene, C2-4 alkenylene of C2-4 alkynylene chain with the proviso that the sum total of carbon atoms in X and Y is not more than 8; Ar represents a phenyl group optionally substituted by one or more substituents selected from halogen atoms, or the groups C1-3 alkyl, C1-3 alkoxy, -(CH2)q OH (where q represents an integer from 0 to 3), - NR<3>R<4> (where R<3> and R<4> each represents a hydrogen atom, or a C1-4 alkyl group, or NR<3>R<4> forms a saturated heterocyclic amino group which has 5-7 ring members and optionally contains in the ring one or more atoms selected from -O- or -S- or a group -NH- or -N(CH3)-), or -NR<5>COR<6> (where R<5> represents a hydrogen atom or a C1-4 alkyl group, and R<6> represents a hydrogen atom or a C1-4 alkyl, C1-4 alkoxy, phenyl or -NR<3>R<4> group), or Ar as a phenyl group may be substituted by an alkylenedioxy group of formula -O(CH2)pO-, where p is 1 or 2; R<1> and R<2> each represents a hydrogen atom or a C1-3 alkyl group, with the proviso that the sum total of carbon atoms in R<1> and R<2> is not more than 4; and physiologically acceptable salts and solvates (e.g. hydrates) thereof. The compounds of formula (I) have a selective stimulent action at beta 2-adrenoceptors and are usful, in particular, in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.
Patent NZ-215134-A (NZ)
Title: 3-acylaminobenzisothiazole-s,s-dioxide and insecticidal compositions
Inventor: DRABEK J
IPC: A01N43/80
Filed: 1986-02-12
Abstract: The invention relates to a novel 3-acylaminobenzisothiazole-S,S-dioxide of formula I    <IMAGE>  (I). to the preparation thereof, to insecticidal compositions containing said compound and to the use thereof for controlling insects, in particular plant-destructive sucking insects.
Patent NZ-218333-A (NZ)
Title: Aromatic compounds that act on peripheral and/or central dopamine receptors
Inventor: INCE FRANCIS
IPC: A61K31/44
Filed: 1986-11-19
Abstract: There are described compounds of formula I, in which X represents a C2 to 8 alkylene chain optionally interrupted by a double bond or by S(O)<sub>n</sub>, wherein n is 0, 1 or 2;Y represents O or NH,l and m each independently represent 2, 3 or 4,R₁₀ represents phenyl substituted by one or more substituents R₂₃, which may be the same or different; or R₁₀ represents pyridyl, a saturated carbocyclic group, alkyl C 1 to 6 or hydrogen,R₁₅ represents hydrogen or together with R₂₃ forms a (CH₂)<sub>p</sub> chain, wherein p represents 0, 1 or 2;R₂₀, R₂₁, R₂₂ and R₂₃, which may be the same or different, independently represent hydrogen, alkyl C 1 to 6, NHR₂₅, SH, NO₂, halogen, CF₃, SO₂R₃₀, CH₂OH or OH, wherein R₂₅, represents hydrogen, alkyl C 1 to 6, alkanoyl C 1 to 6 or SO₂ alkyl C 1 to 6, and R₃₀ represents alkyl C 1 to 6 or NH₂,provided that when X represents an uninterrupted C4 alkylene chain, Y represents NH, m represents 2, l represents 2, R₁₀ represents phenyl, R₁₅ represents hydrogen, and R₂₁, R₂₂ and R₂₃ represent hydrogen, then R₂₀ does not represent hydrogen or 4-OH,and pharmaceutically acceptable salts and solvates thereof.There are also described processes for the preparation of the compounds of formula I and pharmaceutical compositions containing them. The compounds of the invention may be used in the treatment or prophylaxis of renal failure or cardiovascular disorders.
Patent NZ-220337-A (NZ)
Title: 4-benzoyl-3,5-dioxotetrahydropyrans, preparation, and compositions
Inventor: CARTER C G
IPC: A01N43/18
Filed: 1987-05-18
Abstract: Compounds of the formula <CHEM>  wherein  X is oxygen, sulfur or sulfonyl; R is halogen; C1-C2 alkyl; C1-C2 alkoxy; nitro; cyano; C1-C2 haloalkyl; or R<a>SOm- wherein m is 0 or 2 and R<a> is C1-C2 alkyl;  R<1> is hydrogen or C1-C4 alkyl;  R<2> is hydrogen or C1-C4 alkyl; or  R<1> and R<2> together are alkylene having 2 to 5 carbon atoms;  R<3> is hydrogen or C1-C4 alkyl;  R<4> is hydrogen or C1-C4 alkyl; or  R<3> and R<4> together are alkylene having 2 to 5 carbon atoms; R<5> and R<6> independently are (1) hydrogen; (2) halogen; (3) C1-C4 alkyl; (4)C1-C4 alkoxy; (5) trifluoromethoxy; (6) cyano; (7) nitro; (8) C1-C4 haloalkyl; (9) R<b>SOn- wherein n is the integer 0, 1 or 2; and R<b> is (a) C1-C4 alkyl; (b) C1-C4 alkyl substituted with halogen or cyano; (c) phenyl; or (d) benzyl; (10) -NR<c>R<d> wherein R<c> and R<d> independently are hydrogen or C1-C4 alkyl; (11) R<e>C(O)- wherein R<e> is C1-C4 alkyl or C1-C4 alkoxy; or (12) -SO2NR<c>R<d> wherein R<c> and R<d> are as defined; and (13) -N(R<c>)C(O)R<d> wherein R<c> and R<d> are as defined and their salts are useful as herbicides.
Patent NZ-224782-A (NZ)
Title: Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase
Inventor: KISHORE GANESH MURTHY
IPC: C12N9/10
Filed: 1988-05-25
Abstract: Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate (EPSP) synthases, DNA encoding glyphosate-tolerant EPSP synthases, plant genes encoding the glyphosate-tolerant enzymes, plant transformation vectors containing the genes, transformed plant cells and differentiated transformed plants containing the plant genes are disclosed. The glyphosate-tolerant EPSP synthases are prepared by substituting an alanine residue for a glycine residue in a conserved sequence found between positions 80 and 120 in the mature wild-type EPSP synthase.
Patent NZ-233677-A (NZ)
Title: Syringe assembly includes a piston of a hardness higher than that of the inner of two coextruded plastics barrel portions
Inventor: DRAGOSITS THOMAS J
IPC: A61M5/31
Filed: 1990-05-15
Abstract: An operable syringe assembly comprises a barrel (21) including a cylindrical coextruded body portion (22) having a longitudinal axis. The body portion (22) forms a side wall (25) spaced from the axis defining a chamber (27) for retaining fluid. The body portion (22) includes an open proximal end (28) and a distal end (29) and further includes an inner portion (31) of plastic material and a rigid portion (32) of plastic material surrounding the inner portion (31). The rigid portion (32) has a higher hardness than the inner portion (31). A plunger (40) including an elongate shaft portion (41) having a proximal end (43), a distal end (44) and a rigid piston (45) at the distal end (44) is provided. The piston (45) has an outside diameter greater than the inside diameter of the inner portion (31) and a higher hardness than the inner portion (31). The piston portion (45) is slidably positioned in fluid-tight engagement inside the barrel (21). The fluid-tight engagement is caused by the piston (45) compressing the inner portion (31) of the plastic material of the coextruded body portion (22). The proximal end (43) of the plunger (40) extends outwardly from the open proximal end (28) of the barrel (21) to facilitate moving the piston portion (45) with respect to the barrel (21).
Patent NZ-240003-A (NZ)
Title: Inhibiting tooth enamel erosion; beverage containing calcium citrate malate
Inventor: ANDON MARK BENSON
IPC: A23L1/304
Filed: 1991-09-30
Abstract: Acidic beverages, e.g. juices and carbonated beverages containing calcium citrate malate are disclosed. These beverages inhibit the erosion of tooth enamel that normally occurs during consumption of acidic beverages. A nutritional regimen of administering an acid beverage (pH below 5.5) containing from 35 mg to 270 mg calcium per 6 ounce (180 ml) serving (0.02% to 0.15% w/v of calcium) in the form of calcium citrate malate, for preventing tooth enamel erosion is disclosed. This beverage comprises water, sweetener and flavor or juice.
Patent NZ-248267-A (NZ)
Title: 1-amino acetamido(optionally substituted)pyrrole derivatives and analogues and pharmaceutical compositions thereof
Inventor: MARTIN LAWRENCE L
IPC: C07D403/14
Filed: 1993-07-28
Abstract: The present invention relates to compounds of the general formula   <CHEM>  wherein   R1 is   hydrogen or loweralkyl; R2 is   hydrogen, loweralkyl, hydroxyloweralkyl, acyloxyloweralkyl or loweralkoxyloweralkyl; R3 is   hydrogen or loweralkyl;  or R2 and R3   taken together form a cycloalkyl ring of 3 to 7 carbon atoms; R4 is   hydrogen, loweralkyl, aryl or arylloweralkyl; R5 is   hydrogen, loweralkyl, acyl, aryloxycarbonyl, loweralkoxycarbonyl, or arylloweralkoxycarbonyl; X is   hydrogen, halogen, cyano, loweralkyl, aryl, arylloweralkyl, hydroxyloweralkyl, arylhydroxyloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, diloweralkylaminoloweralkyl, arylsulfonyl, loweralkylsulfonyl; m and n are   independently 0 to 5 with the proviso that the sum of m and n does not exceed 5; p is   0, 1 or 2; and wherein the dotted line between the pyrrole ring and the carbonyl group represents an optional bond; when said bond ist present, R6 is hydrogen, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, or <CHEM> where Y is hydrogen, halogen, loweralkyl, loweralkoxy, hydroxy, trifluormethyl or nitro; or heteroaryl selected from <CHEM> where Z is hydrogen, halogen or loweralkyl, with the proviso that when m and n are each zero and when R2 and R3 are each hydrogen and R6 is phenyl or substituted phenyl and together with he carbonyl group is attached at the 2-position of the pyrrole ring, Y cannot be hydrogen, halogen, trifluoromethyl or nitro; or a pharmaceutically acceptable acid addition salt thereof, or where applicable an optical or geometrical isomer or racemic mixture thereof. The compounds of this invention are useful as glycine partial agonists and for the enhancement of learning and memory and in the treatment of memory dysfunction associated with neurodegenerative disorders and are thus indicated in the treatment of Alzheimer's disease and other senile demantias.
Patent NZ-250218-A (NZ)
Title: Quinazoline derivatives, preparation and pharmaceutical compositions thereof
Inventor: BARKER ANDREW JOHN
IPC: C07D401/04
Filed: 1993-11-17
Abstract: The invention concerns quinazoline derivatives of the formula I <CHEM> wherein m is 1, 2 or 3 and each R<1> includes hydroxy, amino, ureido, hydroxyamino, trifluoromethoxy, (1-4C)alkyl, (1-4C)alkoxy and (1-3C)alkylenedioxy; and and Q is a 9- or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen heteroatoms and optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur, or Q is a 9- or 10-membered bicyclic aryl moiety which heterocyclic or aryl moiety may optionally bear one or two substituents selected from halogeno, hydroxy, oxo, amino, nitro, carbamoyl, (1-4C)alkyl, (1-4C)alkoxy, (1-4C)alkylamino, di-[(1-4C)alkyl]amino and (2-4C)alkanoylamino; or a pharmaceutically-acceptable salt thereof; processes for their preparation; pharmaceutical compositions containing them; and the use of the receptor tyrosine kinase inhibitory properties of the compounds in the treatment of cancer.
Patent NZ-257578-A (NZ)
Title: Process for the preparation of taxane derivatives; 1,3-oxazolidine reagent
Inventor: DENIS JEAN-NOEL
IPC: C07D305/14
Filed: 1993-10-28
Abstract: Taxane derivatives and a method of preparing taxane derivatives of formula (I):  are disclosed. In general formula (I), Ar represents an aryl radical; R represents a phenyl radical or a radical R5-O- in which R5 represents an alkyl, alkenyl, alkynyl, cycloalkyl, phenyl or saturated or unsaturated nitrogenous heterocylcyl radical, R1 and R2, which are identical or different, each represent a hydrogen atom or an alkyl, phenylalkyl, phenyl, alkoxyphenyl, or dialkoxyphenyl radical, or else R1 and R2 form, together with the carbon atom to which they are bonded, a ring having from 4 to 7 members; R3 represents an acetyl radical or a protecting group of the hydroxyl functional group; and R4 represents a protecting group of the hydroxyl functional group.
Patent NZ-261414-A (NZ)
Title: N-acyl-2-(diphenylalkyl)piperidine derivatives and pharmaceutical compositions
Inventor: SUNKARA SAI PRASAD
IPC: A61K31/454
Filed: 1993-12-17
Abstract: PCT No. PCT/US93/12300 Sec. 371 Date Mar. 11, 1996 Sec. 102(e) Date Mar. 11, 1996 PCT Filed Dec. 17, 1993 PCT Pub. No. WO94/17040 PCT Pub. Date Aug. 4, 1994Diarylalkyl piperidines of formula (1)    <IMAGE>  (1)  reverse drug resistance in multi-drug resistant tumors. These compounds apparently function by inhibiting a p-glycoprotein pump which becomes activated in late stage tumor development and which is inherently present in tumors from certain origins.
Patent NZ-262889-A (NZ)
Title: Road use tracking and billing system
Inventor: WIDL ANDREAS
IPC: G06Q30/02
Filed: 1994-03-10
Abstract: The route identification system includes a wireless system installed independently of the geographical one and outside of the moving object to transmit information for detection of the actual geographic position of the object. A receiver system carried by the object receives the position detection information. A permanent memory is provided for the moving object to characterise individual routes on the route network and/or geographical zone. The position of the object is compared to the stored route position so that the geographic position of the object can be constantly identified.
Patent NZ-283069-A (NZ)
Title: Rotary ic engine has spherical pistons rolling on annular cam ring
Inventor: DALE THOMAS W
IPC: F02B57/04
Filed: 1995-03-14
Abstract: A rotary internal combustion engine comprising a housing containing a rotatable cylinder having a circular wall containing at least two rows of radially extending circular passageways forming compression and power engine cylinders, respectively, displaced from each other along the axis of rotation. Each of the engine cylinders contains a freely reciprocal and rotatable spherical piston. A stationary cam is mounted within the housing surrounding each of the rows of engine cylinders, each cam consisting of a pair of edges circular in diameter whose axis coincides with the axis of rotation of the rotatable cylinder. Each pair of edges is in contact with all of the spherical pistons within its respective row, the spacing of the edges varying over 360 degrees of rotation so that the spherical pistons move at a uniform velocity within each cylinder.
Patent NZ-290066-A (NZ)
Title: Biscyclopentadienyl diene transition metal complexes, suitable for olefin polymerisation
Inventor: TIMMERS FRANCIS J
IPC: C08F4/659
Filed: 1995-07-14
Abstract: Catalysts for polymerizing olefins, diolefins and/or acetylenically unsaturated monomers comprising biscyclopentadienyl, Group 4 transition metal complexes formed with conjugated dienes wherein the diene is bound to the transition metal either in the form of a  sigma -complex or a  pi -complex in combination with a cocatalyst or subjected to bulk electrolysis in the presence of compatible, inert non-coordinating anions.
Patent NZ-330464-A (NZ)
Title: Methods for the preparation of biphenyl isoxazole sulfonamides
Inventor: POLNIASZEK RICHARD P
IPC: C07D413/12
Filed: 1997-02-19
Abstract: ethods for the preparation of biphenyl isoxazole sulfonamides of the formula 1 and 1a and intermediates thereof are disclosed. The biphenyl isoxazole sulfonamides prepared by the present methods are endothelin antagonists useful, inter alia, for the treatment of hypertension.
Patent NZ-334614-A (NZ)
Title: Solid core antenna for radio telephone
Inventor: LEISTEN OLIVER PAUL
IPC: H01Q11/08
Filed: 1995-08-21
Abstract: A radio telephone antenna for operation at frequencies of more than 200MHz (preferably 500MHz) has a solid insulative core 12 of material with relative dielectric constant greater than 5, a three dimensional antenna structure 10 disposed on the outer surface of the core and defining an interior space, and a feeder structure 14, 18 passing through the core and connected to the antenna structure.  The material of the core occupies the major part of the interior space.
Patent NZ-337109-A (NZ)
Title: Method for adminstering an agarose collagen bead for suppressing tumor cell proliferation
Inventor: JAIN KANTI
IPC: A61K35/22
Filed: 1999-08-06
Abstract: The present invention relates to conditioned medium produced by incubating at least one agarose coated, solid agarose collagen bead, or at least one solid, agarose coated, agarose containing bead, under appropriate conditions, and collecting the medium with appropriate means, a diffusible biological product contained in said conditioned medium and the use of same for the preparation of a medicament.
Patent NZ-503430-A (NZ)
Title: Testing device for determining analytes in a liquid dairy product
Inventor: DEGELAEN JACQUES
IPC: G01N33/558
Filed: 1998-10-06
Abstract: A testing device for determining analytes in a liquid dairy product by capillary migration of the dairy product, comprising a solid support (1) having a first and a second end, whereon are fixed, successively, starting from the first end: a membrane (2) for purifying the analysed liquid, a membrane (3) whereon one or several capturing substances are immobilised, and an absorbing membrane (4).
Patent NZ-512404-A (NZ)
Title: Triphasic oral contraceptive comprising an estrogen and a progestogen administrated over 21 days
Inventor: UPMALIS DAVID
IPC: A61K31/565
Filed: 1999-12-08
Abstract: A method of contraception which comprises administrating a combination of 17a-ethinylestradiol and norgestimate for 21 successive days to a female of childbearing age. For the first 7 days in a daily dose of 25mg of 17a-ethinylestradiol and 0.18mg of norgestimate. For the next 7 days in a daily dose of 25mg of 17a-ethinylestradiol and 0.215mg of norgestimate. For the next 7 days a daily dose of 25mg of 17a-ethinylestradiol and 0.25mg of norgestimate. The next 7 days there is no estrogen and progestogen administration. Also described is a triphasic oral contraceptive unit having 21 separate dosage units, each unit containing a combination of an estrogen and a progestogen.
Patent NZ-513713-A (NZ)
Title: Method for increasing filler retention of cellulosic fiber sheets
Inventor: JEWELL RICHARD A
IPC: D21H17/68
Filed: 2000-03-16
Abstract: A method for increasing filler retention of cellulosic fiber sheets is disclosed, wherein cellulosic fibers with increased anionic sites are treated with either positively charged filler particles and/or amphoteric filler particles or a cationic retention aid and negatively charged filler particles and/or amphoteric filler particles. Cellulosic fiber sheets with retained filler particles are also disclosed.